Subscribe to Newsletter
Inside the Lab Microbiology and immunology

Under the Sea

| Roisin McGuigan

Shortages of Gelidium are affecting the global supply of agar, driving up prices and causing decreased availability

Diagnostics Histology

Printed Pathology

| Hany Osman

A 3D-printed prototype in vivo microscope may make an expensive technology cheap and customizable

Inside the Lab Profession

A Cure-All For Block Management Woes?

| Valérie Costes Martineau, Laure Dumas, Nicolas Leventoux

Automated paraffin block storage systems can increase traceability and security while reducing the time and effort needed to sort and store

Outside the Lab Point of care testing

Another Blow for Fingerprick Diagnostics

| Roisin McGuigan

The demand for simple, point-of-care fingerprick testing is growing, but could a study highlighting drop-to-drop sample variation throw a spanner in the works?

Diagnostics Hematology

The Many Faces of Follicular Lymphoma

| German Ott

Follicular lymphoma is currently viewed as a single disease entity – but will recent pathologic findings redefine our perspective?

Diagnostics Profession

An Award-Winning Career

| Fedra Pavlou

Voted Number One on The Pathologist Power List, Manuel Sobrinho-Simões, talks profession, politics, education, innovation, and the ups and the downs of a career that has inspired generations of pathologists.

Outside the Lab Digital and computational pathology

Our Technological Crutches

| Fedra Pavlou

Is almost complete reliance on technology a good thing?

Diagnostics Oncology

Building a Better Mousetrap

| Michael Schubert

It’s often difficult to target pancreatic cancer cells while sparing healthy tissue – but a new therapy concept not only makes this possible, but also enhances the potential effectiveness of adjuvant treatments

Diagnostics Oncology

An Epigenetic Epiphany

| Michael Schubert

When genetics yielded unsatisfactory answers about pancreatic cancer’s persistent survival, researchers looked beyond the genome – and found telling epigenetic changes

Subspecialties Oncology

Breaching Cancer’s Defenses

| Ingunn Stromnes

A new immunotherapy approach shows that engineered T cells are able to penetrate into pancreatic tumors and directly attack the cancer

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register